tiprankstipranks
Fennec Pharmaceuticals (FENC)
NASDAQ:FENC
US Market
FENC
Fennec Pharmaceuticals
RESEARCH TOOLSreports
Want to see FENC full AI Analyst Report?

Fennec Pharmaceuticals (FENC) Income Statement

256 Followers

Fennec Pharmaceuticals Income Statement

Last quarter (Q4 2025), Fennec Pharmaceuticals's total revenue was $13.99M, an increase of 76.51% from the same quarter last year. In Q4, Fennec Pharmaceuticals's net income was $-5.22M. See Fennec Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 45.42M$ 47.54M$ 21.25M$ 1.53M$ 0.00
Gross Profit
$ 41.59M$ 44.35M$ 19.99M$ 1.45M$ 0.00
Operating Expenses
$ 48.46M$ 41.79M$ 32.76M$ 24.04M$ 17.22M
Depreciation and Amortization
$ 0.00$ 800.00K$ 287.00K$ 149.00K$ 17.22M
EBITDA
$ -6.86M$ 4.80M$ -12.65M$ -22.74M$ -17.18M
Operating Income
$ -6.86M$ 2.57M$ -12.77M$ -22.59M$ -17.22M
Other Income/Expenses
$ -3.41M$ -2.64M$ -3.27M$ -1.13M$ -123.00K
Pretax Income
$ -10.27M$ -71.00K$ -16.05M$ -23.71M$ -17.35M
Net Income
$ -10.27M$ -436.00K$ -16.05M$ -23.86M$ -17.46M
Per Share Metrics
Basic EPS
$ -0.36$ -0.02$ -0.60$ -0.91$ -0.67
Diluted EPS
$ -0.36$ -0.02$ -0.60$ -0.91$ -0.67
Weighted Average Shares Outstanding
 28.58M 21.80M 26.57M 26.27M 25.89M
Weighted Average Shares Outstanding (Diluted)
 28.58M 27.30M 26.57M 26.27M 26.01M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History